Liv B. Gansmo

539 total citations
16 papers, 417 citations indexed

About

Liv B. Gansmo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Liv B. Gansmo has authored 16 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Liv B. Gansmo's work include Cancer-related Molecular Pathways (11 papers), Epigenetics and DNA Methylation (9 papers) and Cancer Genomics and Diagnostics (6 papers). Liv B. Gansmo is often cited by papers focused on Cancer-related Molecular Pathways (11 papers), Epigenetics and DNA Methylation (9 papers) and Cancer Genomics and Diagnostics (6 papers). Liv B. Gansmo collaborates with scholars based in Norway, United States and Netherlands. Liv B. Gansmo's co-authors include Stian Knappskog, Per Eystein Lønning, Lars J. Vatten, Kristian Hveem, Florian Gebauer, Pedro Corrêa de Sampaio, Raghu Kalluri, Valerie S. LeBleu, Jena Tavormina and Sónia A. Melo and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Cancer.

In The Last Decade

Liv B. Gansmo

16 papers receiving 414 citations

Peers

Liv B. Gansmo

ONCOL

PRM

PFM

Eiji Kiyohara Japan

Ibai Goicoechea Spain

Cinzia Bersani Sweden

Ashleigh C. McEvoy Australia

Fui Teen Chong Singapore

Carolina Domínguez Spain

Susanne Sprung Austria

Tim Mosbruger United States

Mélinda Charrier France

Eiji Kiyohara Japan

Liv B. Gansmo

302 ×1.0

175 ×0.7

145 ×0.8

ONCOL

53 ×1.0

PRM

43 ×1.3

PFM

Citations per year, relative to Liv B. Gansmo Liv B. Gansmo (= 1×) peers Eiji Kiyohara

Countries citing papers authored by Liv B. Gansmo

Since Specialization

Citations

This map shows the geographic impact of Liv B. Gansmo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liv B. Gansmo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liv B. Gansmo more than expected).

Fields of papers citing papers by Liv B. Gansmo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liv B. Gansmo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liv B. Gansmo. The network helps show where Liv B. Gansmo may publish in the future.

Co-authorship network of co-authors of Liv B. Gansmo

This figure shows the co-authorship network connecting the top 25 collaborators of Liv B. Gansmo. A scholar is included among the top collaborators of Liv B. Gansmo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liv B. Gansmo. Liv B. Gansmo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Krakstad, Camilla, Mari K. Halle, Tracy A. O’Mara, et al.. (2022). APOBEC3A/B deletion polymorphism and endometrial cancer risk. Cancer Medicine. 12(6). 6659–6667. 2 indexed citations

Gansmo, Liv B., Benedicte A. Lie, Lars J. Vatten, et al.. (2021). Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis. Gene. 793. 145747–145747. 7 indexed citations

Gansmo, Liv B., Merete Bjørnslett, Pål Romundstad, et al.. (2021). Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer. Scientific Reports. 11(1). 23463–23463. 7 indexed citations

Helwa, Reham, Liv B. Gansmo, Merete Bjørnslett, et al.. (2021). Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer. Biomarkers. 26(4). 302–308. 4 indexed citations

Gansmo, Liv B., et al.. (2017). The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells. Translational Oncology. 10(5). 806–817. 5 indexed citations

Gansmo, Liv B., et al.. (2017). Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells. BMC Cell Biology. 18(1). 17–17. 16 indexed citations

Gansmo, Liv B., Merete Bjørnslett, Mari K. Halle, et al.. (2017). MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk. BMC Cancer. 17(1). 97–97. 18 indexed citations

Yang, Sujuan, Paul Kurywchak, Jena Tavormina, et al.. (2017). Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer. Cancer Biology & Therapy. 18(3). 158–165. 192 indexed citations

Gansmo, Liv B., P. Romundstad, Kristian Hveem, et al.. (2017). APOBEC3A/B deletion polymorphism and cancer risk. Carcinogenesis. 39(2). 118–124. 39 indexed citations

10.

Gansmo, Liv B., Lars J. Vatten, Pål Romundstad, et al.. (2016). Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate. Oncotarget. 7(19). 28637–28646. 22 indexed citations

11.

Knappskog, Stian, Beryl Leirvaag, Liv B. Gansmo, et al.. (2016). Prevalence of the CHEK2 R95* germline mutation. Hereditary Cancer in Clinical Practice. 14(1). 19–19. 6 indexed citations

12.

Helwa, Reham, Liv B. Gansmo, Pål Romundstad, et al.. (2016). MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer. Scientific Reports. 6(1). 33153–33153. 8 indexed citations

13.

Gansmo, Liv B., Merete Bjørnslett, Mari K. Halle, et al.. (2016). The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian—but not endometrial cancer. Tumor Biology. 37(8). 10697–10702. 22 indexed citations

14.

Gansmo, Liv B., Pål Romundstad, Kristian Hveem, et al.. (2015). MDM4 SNP34091 (rs4245739) and its effect on breast‐, colon‐, lung‐, and prostate cancer risk. Cancer Medicine. 4(12). 1901–1907. 31 indexed citations

15.

Gansmo, Liv B., Stian Knappskog, Pål Romundstad, et al.. (2014). Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon. International Journal of Cancer. 137(1). 96–103. 28 indexed citations

16.

Knappskog, Stian, Liv B. Gansmo, Pål Romundstad, et al.. (2012). MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk. PLoS ONE. 7(4). e36263–e36263. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact